These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 38263401)

  • 1. Non-alcoholic fatty liver disease promotes liver metastasis of colorectal cancer via fatty acid synthase dependent EGFR palmitoylation.
    Zhang C; Zhang Y; Dong Y; Zi R; Wang Y; Chen Y; Liu C; Wang J; Wang X; Li J; Liang H; Ou J
    Cell Death Discov; 2024 Jan; 10(1):41. PubMed ID: 38263401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The progress of non-alcoholic fatty liver disease as the risk of liver metastasis in colorectal cancer.
    Lv Y; Patel N; Zhang HJ
    Expert Rev Gastroenterol Hepatol; 2019 Dec; 13(12):1169-1180. PubMed ID: 31774328
    [No Abstract]   [Full Text] [Related]  

  • 3. Enhanced De Novo Lipid Synthesis Mediated by FASN Induces Chemoresistance in Colorectal Cancer.
    Han L; Dai W; Luo W; Ye L; Fang H; Mo S; Li Q; Xu Y; Wang R; Cai G
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765520
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Czumaj A; Zabielska J; Pakiet A; Mika A; Rostkowska O; Makarewicz W; Kobiela J; Sledzinski T; Stelmanska E
    Anticancer Res; 2019 Jul; 39(7):3815-3822. PubMed ID: 31262909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of de novo Palmitate Synthesis by Fatty Acid Synthase Induces Apoptosis in Tumor Cells by Remodeling Cell Membranes, Inhibiting Signaling Pathways, and Reprogramming Gene Expression.
    Ventura R; Mordec K; Waszczuk J; Wang Z; Lai J; Fridlib M; Buckley D; Kemble G; Heuer TS
    EBioMedicine; 2015 Aug; 2(8):808-24. PubMed ID: 26425687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatty acid synthase mediates EGFR palmitoylation in EGFR mutated non-small cell lung cancer.
    Ali A; Levantini E; Teo JT; Goggi J; Clohessy JG; Wu CS; Chen L; Yang H; Krishnan I; Kocher O; Zhang J; Soo RA; Bhakoo K; Chin TM; Tenen DG
    EMBO Mol Med; 2018 Mar; 10(3):. PubMed ID: 29449326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NOD-like receptor C4 Inflammasome Regulates the Growth of Colon Cancer Liver Metastasis in NAFLD.
    Ohashi K; Wang Z; Yang YM; Billet S; Tu W; Pimienta M; Cassel SL; Pandol SJ; Lu SC; Sutterwala FS; Bhowmick N; Seki E
    Hepatology; 2019 Nov; 70(5):1582-1599. PubMed ID: 31044438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular vesicles in fatty liver promote a metastatic tumor microenvironment.
    Wang Z; Kim SY; Tu W; Kim J; Xu A; Yang YM; Matsuda M; Reolizo L; Tsuchiya T; Billet S; Gangi A; Noureddin M; Falk BA; Kim S; Fan W; Tighiouart M; You S; Lewis MS; Pandol SJ; Di Vizio D; Merchant A; Posadas EM; Bhowmick NA; Lu SC; Seki E
    Cell Metab; 2023 Jul; 35(7):1209-1226.e13. PubMed ID: 37172577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatty Acid Synthase-Suppressor Screening Identifies Sorting Nexin 8 as a Therapeutic Target for NAFLD.
    Hu Y; He W; Huang Y; Xiang H; Guo J; Che Y; Cheng X; Hu F; Hu M; Ma T; Yu J; Tian H; Tian S; Ji YX; Zhang P; She ZG; Zhang XJ; Huang Z; Yang J; Li H
    Hepatology; 2021 Nov; 74(5):2508-2525. PubMed ID: 34231239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of de novo synthesized palmitate and mitochondrial EGFR in EGF induced mitochondrial fusion of cancer cells.
    Bollu LR; Ren J; Blessing AM; Katreddy RR; Gao G; Xu L; Wang J; Su F; Weihua Z
    Cell Cycle; 2014; 13(15):2415-30. PubMed ID: 25483192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Non-alcoholic Fatty Liver Disease on the Risk of Synchronous Liver Metastasis: Analysis of 451 Consecutive Patients of Newly Diagnosed Colorectal Cancer.
    Lv Y; Zhang HJ
    Front Oncol; 2020; 10():251. PubMed ID: 32181157
    [No Abstract]   [Full Text] [Related]  

  • 12. CD36 palmitoylation disrupts free fatty acid metabolism and promotes tissue inflammation in non-alcoholic steatohepatitis.
    Zhao L; Zhang C; Luo X; Wang P; Zhou W; Zhong S; Xie Y; Jiang Y; Yang P; Tang R; Pan Q; Hall AR; Luong TV; Fan J; Varghese Z; Moorhead JF; Pinzani M; Chen Y; Ruan XZ
    J Hepatol; 2018 Sep; 69(3):705-717. PubMed ID: 29705240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chaihu Shugan powder influences nonalcoholic fatty liver disease in rats in remodeling microRNAome and decreasing fatty acid synthesis.
    Zheng C; Nie H; Pan M; Fan W; Pi D; Liang Z; Liu D; Wang F; Yang Q; Zhang Y
    J Ethnopharmacol; 2024 Jan; 318(Pt A):116967. PubMed ID: 37506783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of fatty acid synthase provides a survival advantage to colorectal cancer cells via upregulation of cellular respiration.
    Zaytseva YY; Harris JW; Mitov MI; Kim JT; Butterfield DA; Lee EY; Weiss HL; Gao T; Evers BM
    Oncotarget; 2015 Aug; 6(22):18891-904. PubMed ID: 25970773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Forkhead box K2 promotes human colorectal cancer metastasis by upregulating ZEB1 and EGFR.
    Du F; Qiao C; Li X; Chen Z; Liu H; Wu S; Hu S; Qiu Z; Qian M; Tian D; Wu K; Fan D; Nie Y; Xia L
    Theranostics; 2019; 9(13):3879-3902. PubMed ID: 31281520
    [No Abstract]   [Full Text] [Related]  

  • 16. Diosgenin attenuates nonalcoholic hepatic steatosis through the hepatic FXR-SHP-SREBP1C/PPARα/CD36 pathway.
    Chen S; Sun S; Feng Y; Li X; Yin G; Liang P; Yu W; Meng D; Zhang X; Liu H; Zhang F
    Eur J Pharmacol; 2023 Aug; 952():175808. PubMed ID: 37263401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amelioration of non-alcoholic fatty liver disease by targeting adhesion G protein-coupled receptor F1 (
    Wu M; Lo TH; Li L; Sun J; Deng C; Chan KY; Li X; Yeh ST; Lee JTH; Lui PPY; Xu A; Wong CM
    Elife; 2023 Aug; 12():. PubMed ID: 37580962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. m6A modified BACE1-AS contributes to liver metastasis and stemness-like properties in colorectal cancer through TUFT1 dependent activation of Wnt signaling.
    Wang X; Liu Y; Zhou M; Yu L; Si Z
    J Exp Clin Cancer Res; 2023 Nov; 42(1):306. PubMed ID: 37986103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-alcoholic fatty liver disease and colorectal cancer survival.
    Wu K; Zhai MZ; Weltzien EK; Cespedes Feliciano EM; Meyerhardt JA; Giovannucci E; Caan BJ
    Cancer Causes Control; 2019 Feb; 30(2):165-168. PubMed ID: 30443695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-alcoholic fatty liver disease and colorectal cancer.
    Mikolasevic I; Orlic L; Stimac D; Hrstic I; Jakopcic I; Milic S
    Postgrad Med J; 2017 Mar; 93(1097):153-158. PubMed ID: 27852946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.